GSK-3b in mouse fibroblasts controls wound healing and fibrosis through an endothelin-1– dependent mechanism
暂无分享,去创建一个
J. Woodgett | M. Kapoor | D. Abraham | C. Denton | Shangxin Liu | A. Leask | X. Shi-wen | M. McCann | Kun Huh
[1] A. Leask. Targeting the TGFbeta, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma. , 2008, Cellular signalling.
[2] M. Permutt,et al. Genetic Deficiency of Glycogen Synthase Kinase-3β Corrects Diabetes in Mouse Models of Insulin Resistance , 2008, PLoS biology.
[3] Shaoqiong Chen,et al. The gene expression profile induced by Wnt 3a in NIH 3T3 fibroblasts , 2007, Journal of Cell Communication and Signaling.
[4] K. Lyons,et al. CTGF(CCN2) is essential for fibroblast function , 2006 .
[5] B. Alman,et al. Prolonged β-catenin stabilization and tcf-dependent transcriptional activation in hyperplastic cutaneous wounds , 2005, Laboratory Investigation.
[6] M. Clozel,et al. Role of endothelin in fibrosis and anti‐fibrotic potential of bosentan , 2005, Annals of medicine.
[7] B. Doble,et al. Glycogen synthase kinase-3 in insulin and Wnt signalling: a double-edged sword? , 2004, Biochemical Society transactions.
[8] Yunliang Chen,et al. Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. , 2004, Molecular biology of the cell.
[9] Michael Koutsilieris,et al. The Akt pathway: molecular targets for anti-cancer drug development. , 2004, Current cancer drug targets.
[10] D. Abraham,et al. Col1a2 enhancer regulates collagen activity during development and in adult tissue repair. , 2004, Matrix biology : journal of the International Society for Matrix Biology.
[11] G. Gabbiani,et al. The myofibroblast in wound healing and fibrocontractive diseases , 2003, The Journal of pathology.
[12] B. Doble,et al. GSK-3: tricks of the trade for a multi-tasking kinase , 2003, Journal of Cell Science.
[13] C. Denton,et al. Ligand-dependent genetic recombination in fibroblasts : a potentially powerful technique for investigating gene function in fibrosis. , 2002, The American journal of pathology.
[14] Hans Clevers,et al. β-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[15] B. Alman,et al. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). , 1997, The American journal of pathology.
[16] Paul Martin,et al. Wound Healing--Aiming for Perfect Skin Regeneration , 1997, Science.
[17] C. Enwemeka,et al. A simplified method for the analysis of hydroxyproline in biological tissues. , 1996, Clinical biochemistry.
[18] H. Stegemann,et al. Determination of hydroxyproline. , 1967, Clinica chimica acta; international journal of clinical chemistry.
[19] Hui Xiong,et al. beta-Catenin activates the growth factor endothelin-1 in colon cancer cells. , 2005, Oncogene.
[20] T. Krieg,et al. Interactions of fibroblasts with the extracellular matrix: implications for the understanding of fibrosis , 2004, Springer Seminars in Immunopathology.
[21] R. Nusse,et al. Convergence of Wnt, beta-catenin, and cadherin pathways. , 2004, Science.
[22] J. Woodgett,et al. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. , 2000, Nature.
[23] S. Byers,et al. Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin. , 1997, The Journal of biological chemistry.
[24] R Kemler,et al. beta-catenin is a target for the ubiquitin-proteasome pathway. , 1997, The EMBO journal.
[25] R Grosschedl,et al. Functional interaction of beta-catenin with the transcription factor LEF-1. , 1996, Nature.